Japan transforms engineered heart tissues for precise drug testing

A research team led by Associate Professor Yoshinori Yoshida and Specially Appointed Assistant Professor Yuya ...

June 7, 2025 | Saturday | News
QureBio raises CNY 100 M in series C1 for accelerating core pipelines

China-based startup Qure Biotechnology (Shanghai) has completed a Series C1 financing round. The financing raised nearly...

June 6, 2025 | Friday | News
Fujirebio strategically collaborates with Stanford Medicine to advance infectious disease research

Fujirebio, a leading innovator in in-vitro diagnostics, has announced a collaboration with Stanford Medicine, ...

June 5, 2025 | Thursday | News
AusBiotech and Austrade launch partnership to accelerate global expansion of life sciences industry

AusBiotech, Australia’s peak body for the life sciences sector, and the Australian Government's Trade and Investme...

June 5, 2025 | Thursday | News
US-Singapore collaboration to develop next generation allogeneic CAR technologies

US-based startup Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-...

June 4, 2025 | Wednesday | News
BioNet and Bio Farma sign strategic MoU to expand TdaP vaccine access in ASEAN

BioNet, a Franco-Thai vaccine biotech group, and PT Bio Farma (Persero), Indonesia's state-owned vaccine manuf...

June 4, 2025 | Wednesday | News
Milestone partnership highlighting Korea’s expanding influence in global biotech innovation

MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascul...

June 3, 2025 | Tuesday | News
Taiwan's KMUH inks MoU with AbbVie to accelerate global clinical trials and advance patient-centered innovation

To accelerate clinical trial activation and execution, enhance research quality, and strengthen international competitiv...

June 3, 2025 | Tuesday | News
Australia's PolyActiva secures AUD $40M in Series C to advance ocular drug delivery

Australia-based PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to im...

June 3, 2025 | Tuesday | News
Sanofi buys Blueprint Medicines for $9.1 B, expanding portfolio in rare immunological disease

French pharmaceutical company Sanofi and Blueprint Medicines Corporation, a US-based, publicly traded biopharmaceutical ...

June 2, 2025 | Monday | News
“APAC now leads global clinical development of multi-specific antibodies, accounting for over 40% of trials”

What are the major plans in store after this acquisition? Is there a phase-wise plan? Following the acquisition, Syngen...

May 31, 2025 | Saturday | Opinion
Upskilling and flexibility are key to staying relevant as hiring grows

The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the wors...

May 31, 2025 | Saturday | Analysis
APAC's Alliance-Driven Biotech Boom

Biotech partnerships of APAC differ in a variety of ways from most global collaborations, primarily due to the unique ge...

May 31, 2025 | Saturday | News
Singapore leads S$10 M national effort to tackle muscle-loss due to ageing

To tackle the growing threat of muscle loss in Singapore’s ageing population, SingHealth Duke-NUS Academic Medical...

May 29, 2025 | Thursday | News
Singapore's EDDC receives US FDA Fast Track Designation for Antibody-Drug Conjugate

The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development,...

May 28, 2025 | Wednesday | News
US FDA-approved Cancer BioShield platform to enter Saudi Arabia and broader Middle East market

ImmunityBio, Inc., a leading immunotherapy company, has announced the signing of a strategic Memorandum of Understanding...

May 28, 2025 | Wednesday | News
Taxis Pharma receives $2.9 M NIH grant to develop therapeutic against antibiotic-resistant Gonorrhea

Taxis Pharmaceuticals, a US-based clinical stage company at the forefront of developing therapies to treat multidrug-res...

May 28, 2025 | Wednesday | News
BioIVT LLC and Handok Biotech sign agreement to advance innovation in South Korea

US-based BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has a...

May 28, 2025 | Wednesday | News